Virus-specific CD4 + T helper lymphocytes are critical to the maintenance of effective immunity
in a number of chronic viral infections, but are characteristically undetectable in chronic …

In the coronavirus efficacy (COVE) phase 3 clinical trial, vaccine recipients were assessed
for neutralizing and binding antibodies as correlates of risk for COVID-19 disease and as …

Cytotoxic T lymphocytes (CTLs) lyse virally infected cells that display viral peptide epitopes
in association with major histocompatibility complex (MHC) class I molecules on the cell …

For many viral infections, resolution of illness is associ-ated with long-term host control of
viremia rather than viral eradication. An example is EBV infection, and the fact that host …

The characterization of the cross-reactive, or heterologous, neutralizing antibody responses
developed during human immunodeficiency virus type 1 (HIV-1) infection and the …

Recent cross-sectional analyses of HIV-1+ plasmas have indicated that broadly cross-reactive
neutralizing antibody responses are developed by 10%–30% of HIV-1+ subjects. The …

CD8 + lymphocytes are believed to be important in host defence against the human
immunodeficiency virus (HIV)-1, inhibiting HIV-1 replication through both cytolytic and non-cytolytic …

Although CD8+ lymphocytes in human immunodeficiency virus type 1 (HIV-1)-infected
individuals have been demonstrated to suppress viral replication, the mechanisms of inhibition …

DC-Dielectrophoresis (DC-DEP), the induced motion of the dielectric particles in a spatially
non-uniform DC electric field, is applied to separate biological cells by size. The locally non-…

Cellular immune responses are thought to be an important antiviral host defense, but the
relationship between virus-specific T-helper and cytotoxic-T-lymphocyte (CTL) responses has …